We are live on
!
Find out more
CA
Claro Advisors Portfolio holdings
AUM
$953M
1-Year Est. Return
24.79%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+24.79%
3 Year Est. Return
+85.48%
5 Year Est. Return
+92.01%
10 Year Est. Return
–
AUM
$278M
AUM Growth
+$40.2M
(+17%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
29.18%
Holding
299
New
44
Increased
168
Reduced
58
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.31M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73M |
| 3 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$1.06M |
| 4 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$1.05M |
| 5 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$863K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$1.97M |
| 2 |
ExxonMobil
XOM
|
+$714K |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$527K |
| 4 |
Cardinal Health
CAH
|
+$514K |
| 5 |
First Trust Technology AlphaDEX Fund
FXL
|
+$395K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.13% |
| 2 | Technology | 17.47% |
| 3 | Consumer Discretionary | 8.96% |
| 4 | Healthcare | 6.92% |
| 5 | Financials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Merck
MRK
$355B
| $594K | 0.21% |
7,747
+106
| +1% | +$8.44K |
|
|
AIO
127
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$831M
| $588K | 0.21% |
23,732
+3,330
| +16% | +$90.5K |
|
128
Hanover Insurance
THG
$8.11B
| $588K | 0.21% |
4,488
+26
| +0.6% | +$3.37K |
|
129
Philip Morris
PM
$303B
| $587K | 0.21% |
6,175
-123
| -2% | -$11.5K |
|
130
Visa
V
$701B
| $587K | 0.21% |
2,708
-62
| -2% | -$13.3K |
|
131
Mastercard
MA
$502B
| $579K | 0.21% |
1,612
+97
| +6% | +$33.5K |
|
132
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.4B
| $578K | 0.21% |
7,499
-9
| -0.1% | -$652 |
|
133
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $575K | 0.21% |
5,134
+22
| +0.4% | +$2.65K |
|
134
Intel
INTC
$513B
| $570K | 0.21% |
11,064
-100
| -0.9% | -$5.11K |
|
135
Uber
UBER
$146B
| $568K | 0.2% |
13,555
-1,069
| -7% | -$46.1K |
|
136
Wells Fargo
WFC
$271B
| $559K | 0.2% |
11,655
+143
| +1% | +$7.04K |
|
137
First Trust Emerging Markets AlphaDEX Fund
FEM
$812M
| $533K | 0.19% |
20,420
+107
| +0.5% | +$2.79K |
|
138
iShares S&P 500 Value ETF
IVE
$49.4B
| $530K | 0.19% |
3,384
+529
| +19% | +$80.4K |
|
139
Adobe
ADBE
$102B
| $520K | 0.19% |
917
-199
| -18% | -$124K |
|
140
Ginkgo Bioworks
DNA
$471M
| $515K | 0.19% |
1,550
+300
| +24% | +$143K |
|
141
Vanguard Morningstar Value ETF
VTV
$190B
| $515K | 0.19% |
3,501
+1,615
| +86% | +$231K |
|
142
Global X US Infrastructure Development ETF
PAVE
$13.4B
| $490K | 0.18% |
17,015
+2,080
| +14% | +$57.8K |
|
143
Fidelity MSCI Information Technology Index ETF
FTEC
$20.8B
| $487K | 0.18% |
+3,597
| New | +$467K |
|
144
iShares Russell 1000 Growth ETF
IWF
$123B
| $487K | 0.18% |
6,368
+308
| +5% | +$22.8K |
|
145
TJX Companies
TJX
$137B
| $487K | 0.18% |
6,417
+302
| +5% | +$20.9K |
|
146
Alibaba
BABA
$272B
| $465K | 0.17% |
3,912
-633
| -14% | -$92.2K |
|
147
Idexx Laboratories
IDXX
$40.2B
| $460K | 0.17% |
699
+2
| +0.3% | +$1.26K |
|
148
Oracle
ORCL
$404B
| $459K | 0.17% |
5,264
-94
| -2% | -$8.83K |
|
149
Medtronic
MDT
$120B
| $458K | 0.16% |
4,431
-576
| -12% | -$66.7K |
|
150
VanEck Short High Yield Muni ETF
SHYD
$456M
| $453K | 0.16% |
+18,000
| New | +$451K |
|
Similar funds
NOCM
VFG
CL
EW
MCM
AWP
LRPA
LA
Claro Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Claro Advisors held 299 positions worth $278M, up 17% from $238M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Claro Advisors deployed $22.4M of net new capital in Q4 2021, opening 44 new positions and adding to 168 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 600 Small Cap ETF: 19,409 shares worth $867K.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 41% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF, an estimated $1.97M trimmed.
- Claro Advisors's largest Q4 2021 buy was State Street SPDR Portfolio S&P 600 Small Cap ETF: 19,409 shares worth $867K.
- Claro Advisors added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $3.31M increase.
- Claro Advisors's biggest Q4 2021 reduction was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF, cutting an estimated $1.97M.
- Claro Advisors fully exited Cardinal Health in Q4 2021, selling an estimated $514K.
- Claro Advisors's ten largest holdings make up 29% of its $278M portfolio in Q4 2021.
- Claro Advisors opened 44 new positions and closed 15 in Q4 2021.
- Claro Advisors's portfolio value rose 17% quarter-over-quarter to $278M.
Based on Claro Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.